Left Ventricular Dysfunction: Clinical Trials

2 trials for Left Ventricular Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2
Phase 11Unknown 1

Follow Left Ventricular Dysfunction: new trials by email Literature Review of Left Ventricular Dysfunction trials Research Report on Left Ventricular Dysfunction

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics of Inhaled Levosimendan
Levosimendan 2.5 milligram/milliliter Injectable Solutiondose Inhaled, Levosimendan 2.5 milligram/milliliter Injectable Solutiondose Intravenous - Left Ventricular Dysfunction
Phase 2UnknownUniversitair Ziekenhuis Brussel62024-02-012024-05-20
Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery
bone marrow mononuclear cells injection, placebo intramyocardial injection - Old Myocardial Infarction, Chronic Myocardial Ischemia
Phase 1 / Phase 2UnknownChinese PLA General Hospital602010-12-012011-01-12

Narrower conditions

Ventricular Dysfunction, Left (2)  ·  Coronary Artery Disease (1)  ·  Respiratory Aspiration (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Ventricular Dysfunction (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Coronary Disease (1)  ·  Myocardial Ischemia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Vascular Diseases (1)

Sponsors

Chinese PLA General Hospital (1)  ·  Universitair Ziekenhuis Brussel (1)

Countries

Belgium (1)  ·  China (1)

Top investigators

Gao Changqing, MD (1)  ·  Matthias Raes, MD (1)